Wissenschaftliche Arbeiten

Prof. Dr. Bülent Karabulut

196 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Targeting apoptosis in the hormone‐ and drug‐resistant prostate cancer cell line, DU‐145, by gossypol/zoledronic acid combination

    Cell Biology International, 2009

    DOI 10.1016/j.cellbi.2009.08.006 PMID 19716895 8 Zitationen (OpenAlex) Quelle: OpenAlex

  2. Trastuzumab Induced Maculopapular Skin Reactions Localized on the Left Forearm and Arm: A Case Report

    Turkiye Klinikleri Tip Bilimleri Dergisi, 2009

    2 Zitationen (OpenAlex) Quelle: OpenAlex

  3. Farmakogenomik: Onkolojide İlaç Kullanımındaki Yenilikler

    Turkiye Klinikleri Medical Oncology - Special Topics, 2009

    Quelle: OpenAlex

  4. CLINICAL EVALUATION OF CIRCULATING CYTOKERATIN 18 AS A BIOMARKER IN COLORECTAL CANCER THERAPY MONITORIZATION

    2009

    Quelle: OpenAlex

  5. Dosetaksel octreotid kombinasyonunun prostat kanseri hücre hatlarında apoptotik proteinler üzerindeki etkilerinin araştırılması

    Çanakkale Onsekiz Mart University AVESIS, 2009

    Quelle: OpenAlex

  6. AT 101 Cisplatin kombinasyonunun insan over kanseri hücre hatları üzerindeki olası sinerjistik sitotoksik ve apoptotik etkilerinin araştırılması

    Çanakkale Onsekiz Mart University AVESIS, 2009

    Quelle: OpenAlex

  7. Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl‐2 protein level in hormone‐refractory prostate cancer cells

    Cell Biology International, 2008

    DOI 10.1016/j.cellbi.2008.11.011 PMID 19103299 43 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  8. Enhancement of docetaxel-induced cytotoxicity and apoptosis by all-trans retinoic acid (ATRA) through downregulation of survivin (BIRC5), MCL-1 and LTbeta-R in hormone- and drug resistant prostate cancer cell line, DU-145

    Journal of Experimental & Clinical Cancer Research, 2008

    DOI 10.1186/1756-9966-27-37 PMID 18789152 28 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  9. Profiling of angiogenic cytokines produced by hormone- and drug-refractory prostate cancer cell lines, PC-3 and DU-145 before and after treatment with gossypol.

    PubMed, 2008

    DOI 10.1684/ecn.2008.0139 PMID 19103523 19 Zitationen (OpenAlex) Quelle: OpenAlex

  10. Pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients.

    PubMed, 2008

    PMID 18979548 7 Zitationen (OpenAlex) Quelle: OpenAlex

  11. Docetaxel and platinum combination chemotherapy in locally advanced or metastatic head and neck cancer.

    PubMed, 2008

    PMID 18555465 4 Zitationen (OpenAlex) Quelle: OpenAlex

  12. [A rare cause of catheter-related bacteremia: Rhizobium radiobacter].

    PubMed, 2008

    PMID 18697434 2 Zitationen (OpenAlex) Quelle: OpenAlex

  13. Rektal skuamöz hücreli karsinom: Bir olgu sunumu ve literatürün gözden geçirilmesi

    2008

    Quelle: OpenAlex

  14. Controlled Release of Methotrexate from W/O Microemulsion and Its In Vitro Antitumor Activity

    Drug Delivery, 2007

    DOI 10.1080/10717540601067760 PMID 17497355 45 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  15. Mature results of neoadjuvant chemotherapy followed by radiotherapy in nasopharyngeal cancer: is it really old fashioned?

    Medical Oncology, 2007

    DOI 10.1007/s12032-007-0052-6 PMID 18188721 2 Zitationen (OpenAlex) Quelle: OpenAlex

  16. Arsenic trioxide exposure to ovarian carcinoma cells leads to decreased level of topoisomerase II and cytotoxicity

    International Journal of Gynecological Cancer, 2006

    DOI 10.1111/j.1525-1438.2006.00626.x PMID 16884364 10 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  17. Single-Agent Irinotecan for Recurrent/Metastatic Colorectal Cancer: A Retrospective Analysis

    Medical Principles and Practice, 2006

    DOI 10.1159/000092992 PMID 16763396 5 Zitationen (OpenAlex) Quelle: OpenAlex

  18. Arsenic trioxide-loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line

    International Journal of Gynecological Cancer, 2006

    DOI 10.1111/j.1525-1438.2006.00557.x PMID 16681722 5 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  19. Therapy, outcome and analysis of c-kit expression in patients with extrapulmonary small cell carcinoma

    International Journal of Clinical Practice, 2005

    DOI 10.1111/j.1368-5031.2005.00447.x PMID 15857349 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  20. Gemcitabine treatment in patients with inoperable locally advanced/metastatic pancreatic cancer and prognostic factors

    Scandinavian Journal of Gastroenterology, 2005

    DOI 10.1080/00365520510023819 PMID 16293561 33 Zitationen (OpenAlex) Quelle: OpenAlex

  21. Predictive value of serum interleukin-8 levels in ovarian cancer patients treated with paclitaxel-containing regimens

    International Journal of Gynecological Cancer, 2005

    DOI 10.1111/j.1525-1438.2005.15210.x PMID 15823106 29 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  22. Potential Predictive Factors for Response to Weekly Paclitaxel Treatment in Patients with Metastatic Breast Cancer

    Journal of Chemotherapy, 2005

    DOI 10.1179/joc.2005.17.1.96 PMID 15828451 17 Zitationen (OpenAlex) Quelle: OpenAlex

  23. A rare extrahepatic syndrome related to acute hepatitis type B: epididymitis in an adolescent.

    PubMed, 2005

    PMID 16013650 9 Zitationen (OpenAlex) Quelle: OpenAlex

  24. Topotecan in Platinum-Resistant Epithelial Ovarian Cancer

    Chemotherapy, 2005

    DOI 10.1159/000088959 PMID 16227688 8 Zitationen (OpenAlex) Quelle: OpenAlex

  25. Gemcitabine plus vinorelbine as first-line treatment of metastatic breast cancer

    Journal of Clinical Oncology, 2005

    DOI 10.1200/jco.2005.23.16_suppl.830 2 Zitationen (OpenAlex) Quelle: OpenAlex

  26. UNEXPECTED SOLITARY BRAIN METASTASIS OF ENDOMETRIAL CARCINOMA IN A PRIMARY INFERTILE WOMAN: REPORT OF A CASE AND REVIEW OF THE LITERATURE

    2005

    Quelle: OpenAlex

  27. Yüksek riskli malign melanomun adjuvan tedavisinde orta yüksek doz interferon alfa-2B tedavisinin etkinliği ve tolerabilitesi

    2005

    Quelle: OpenAlex

  28. Daha önceden antrasiklin ve taksan tedavisi almış metastatik meme kanserli hastalarda gemsitabin tedavisi

    2005

    Quelle: OpenAlex

  29. Our Experience in the Neo-Adjuvant Therapy of Osteogenic Sarcoma

    The Anatolian Journal of General Medical Research, 2005

    DOI 10.5222/terh.2005.15799 Frei zugänglicher VolltextQuelle: OpenAlex

  30. Differential Effects of Doxorubicin and Docetaxel on Nitric Oxide Production and Inducible Nitric Oxide Synthase Expression in MCF-7 Human Breast Cancer Cells

    Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, 2004

    DOI 10.3727/0965040041292305 PMID 15301429 19 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  31. Preparation of Arsenic Trioxide-Loaded Microemulsion and Its Enhanced Cytotoxicity on MCF-7 Breast Carcinoma Cell Line

    Drug Delivery, 2004

    DOI 10.1080/10717540490494096 PMID 15736829 12 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  32. Capecitabine (X) monotherapy in patients (pts) with pretreated metastatic breast cancer (MBC): Is response correlated to cerbB-2 expression?

    Journal of Clinical Oncology, 2004

    DOI 10.1200/jco.2004.22.14_suppl.760 2 Zitationen (OpenAlex) Quelle: OpenAlex

  33. Bioembolisation for unresectable hepatocellular carcinoma: preliminary results of a translational research study.

    PubMed, 2004

    PMID 15595628 1 Zitation (OpenAlex) Quelle: OpenAlex

  34. Abstract #24: Dual Effect of Ocreotide on Du-145 Prostate Carcinoma Cell Line: From Growth Proliferation to Reversal of Chemoresistance

    Endocrine Practice, 2004

    DOI 10.1016/s1530-891x(20)46303-7 Quelle: OpenAlex

  35. Alterations in the activity and expression of serine/threonine protein phosphatases during all trans retinoic acid-induced apoptosis in breast cancer cells

    Oncology Reports, 2003

    DOI 10.3892/or.10.6.2083 PMID 14534748 5 Zitationen (OpenAlex) Quelle: OpenAlex

  36. MEME KANSERİNDE C-ERBB-2 EKSPRESYONU İLE DİĞER PROGNOSTİK FAKTÖRLER ARASINDA İLİŞKİ VAR MI ?

    DergiPark (Istanbul University), 2003

    DOI 10.19161/etd.14628 Quelle: OpenAlex

  37. MEME KANSERİNDE Kİ-67 EKSPRESYONU VE DİĞER PROGNOSTİK FAKTÖRLER İLE İLİŞKİSİ

    DergiPark (Istanbul University), 2003

    DOI 10.19161/etd.91419 Frei zugänglicher VolltextQuelle: OpenAlex

  38. Which dosing scheme is suitable for the taxanes? anin vitro model

    Archives of Pharmacal Research, 2002

    DOI 10.1007/bf02976617 PMID 12214871 8 Zitationen (OpenAlex) Quelle: OpenAlex

  39. Gemcitabine and Vinorelbine Combination in Patients with Metastatic Breast Cancer

    The Breast Journal, 2002

    DOI 10.1046/j.1524-4741.2002.08308.x PMID 12047474 20 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  40. Eosinophilia in the course of gastric carcinoma: Case report Mide karsinomu seyrinde eozinofili: Olgu sunumu

    2002

    Quelle: OpenAlex

  41. Akciğerin Metastatik Tümörlerinin Cerrahi Sağaltım Sonuçları 19 Olguluk Heterojen Bir Dizi

    2002

    Quelle: OpenAlex

  42. Small Cell Neuroendocrine Carcinoma of the Thymus Complicated by Cushing's Syndrome

    Pathology - Research and Practice, 2001

    DOI 10.1016/s0344-0338(04)70023-0 PMID 11261817 7 Zitationen (OpenAlex) Quelle: OpenAlex

  43. Hepatosellüler kanser tanısı konmuş hastalarda p53 mutasyonu sıklığı ve klinikopatolojik korelasyon.

    2001

    Quelle: OpenAlex

  44. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.

    PubMed, 2000

    PMID 11156257 189 Zitationen (OpenAlex) Quelle: OpenAlex

  45. Nodüler Melanomda Dokuz Yıllık Uygulama ve Sonuçlarımız

    DergiPark (Istanbul University), 2000

    Quelle: OpenAlex

  46. Arsenic trioxide-mediated cytotoxicity in prostate and ovarian carcinoma lines.

    1999

    1 Zitation (OpenAlex) Quelle: OpenAlex